S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
NASDAQ:XDNA

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Price, Holdings, & News

$7.38
0.00 (0.00%)
(As of 02/26/2024 ET)
Today's Range
$7.38
$7.38
50-Day Range
$7.38
$7.38
52-Week Range
$5.87
$11.83
Volume
N/A
Average Volume
3,034 shs
Market Capitalization
$2.21 million
Assets Under Management
$2.58 million
Dividend Yield
0.12%
Net Expense Ratio
0.78%
XDNA stock logo

About Kelly CRISPR & Gene Editing Technology ETF (NASDAQ:XDNA)

The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly.

XDNA Stock Price History

XDNA ETF News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Gene editing is now a medical reality
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
3 Biotech Stocks That Are Betting on the Future of Gene Editing
See More Headlines
Receive XDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kelly CRISPR & Gene Editing Technology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Kelly Strategic Management
Fund Name
Kelly CRISPR & Gene Editing Technology ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:XDNA
Inception Date
1/12/2022
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Strategic CRISPR & Gene Editing Technology Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
2

Fund Statistics

Assets Under Management
$2.58 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Kelly Strategic Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Jane Street

Miscellaneous

Beta
0.92
Creation Unit
25,000
Creation Fee
$250.00
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Kelly CRISPR & Gene Editing Technology ETF Expenses

TypeXDNATheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.78%0.57%0.54%0.47%0.51%
Other Expenses0.00%0.71%0.55%0.33%0.58%
Total Expense0.78%0.72%0.70%0.57%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.20%-0.57%
Net Expense0.78%0.59%0.60%0.53%0.58%

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Holdings















XDNA ETF - Frequently Asked Questions

How have XDNA shares performed in 2024?

Kelly CRISPR & Gene Editing Technology ETF's stock was trading at $7.38 at the beginning of the year. Since then, XDNA stock has increased by 0.0% and is now trading at $7.38.
View the best growth stocks for 2024 here
.

What does XDNA invest in?

Kelly CRISPR & Gene Editing Technology ETF is a equity fund issued by Kelly Strategic Management. XDNA focuses on theme investments and follows the Strategic CRISPR & Gene Editing Technology Index. The fund's investments total to approximately $2.58 million assets under management.

What stocks does Kelly CRISPR & Gene Editing Technology ETF hold?
What is the management fee for Kelly CRISPR & Gene Editing Technology ETF?

Kelly CRISPR & Gene Editing Technology ETF's management fee is 0.78% and has no other recorded expenses or fee waivers. The net expense ratio for XDNA is 0.78%.

How do I buy shares of Kelly CRISPR & Gene Editing Technology ETF?

Shares of XDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XDNA) was last updated on 2/26/2024 by MarketBeat.com Staff